KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Receivables - Other: 2015-2025

Historic Receivables - Other for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $10.7 million.

  • Medpace Holdings' Receivables - Other rose 59.65% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 59.65%. This contributed to the annual value of $5.3 million for FY2024, which is 76.21% down from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Receivables - Other is $10.7 million, which was up 78.51% from $6.0 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Receivables - Other peaked at $43.8 million during Q2 2022, and registered a low of $5.3 million during Q4 2024.
  • In the last 3 years, Medpace Holdings' Receivables - Other had a median value of $8.9 million in 2024 and averaged $16.7 million.
  • As far as peak fluctuations go, Medpace Holdings' Receivables - Other slumped by 81.09% in 2024, and later surged by 59.65% in 2025.
  • Quarterly analysis of 5 years shows Medpace Holdings' Receivables - Other stood at $36.1 million in 2021, then increased by 11.90% to $40.4 million in 2022, then tumbled by 44.38% to $22.5 million in 2023, then plummeted by 76.21% to $5.3 million in 2024, then surged by 59.65% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $6.0 million for Q2 2025, and $6.3 million during Q1 2025.